The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice
Abstract
Aims: The mechanisms underlying ageing-induced vascular remodelling remain unclear. This study investigates the role and underlying mechanisms of the cytoplasmic deacetylase sirtuin 2 (SIRT2) in ageing-induced vascular remodelling. Methods and results: Transcriptome and quantitative real-time PCR data were used to analyse sirtuin expression. Young and old wild-type and Sirt2 knockout mice were used to explore vascular function and pathological remodelling. RNA-seq, histochemical staining, and biochemical assays were used to evaluate the effects of Sirt2 knockout on the vascular transcriptome and pathological remodelling and explore the underlying biochemical mechanisms. Among the sirtuins, SIRT2 had the highest levels in human and mouse aortas. Sirtuin 2 activity was reduced in aged aortas, and loss of SIRT2 accelerated vascular ageing. In old mice, SIRT2 deficiency aggravated ageing-induced arterial stiffness and constriction–relaxation dysfunction, accompanied by aortic remodelling (thickened vascular medial layers, breakage of elastin fibres, collagen deposition, and inflammation). Transcriptome and biochemical analyses revealed that the ageing-controlling protein p66Shc and metabolism of mitochondrial reactive oxygen species (mROS) contributed to SIRT2 function in vascular ageing. Sirtuin 2 repressed p66Shc activation and mROS production by deacetylating p66Shc at lysine 81. Elimination of reactive oxygen species by MnTBAP repressed the SIRT2 deficiency–mediated aggravation of vascular remodelling and dysfunction in angiotensin II–challenged and aged mice. The SIRT2 coexpression module in aortas was reduced with ageing across species and was a significant predictor of age-related aortic diseases in humans. Conclusion: The deacetylase SIRT2 is a response to ageing that delays vascular ageing, and the cytoplasm–mitochondria axis (SIRT2–p66Shc–mROS) is important for vascular ageing. Therefore, SIRT2 may serve as a potential therapeutic target for vascular rejuvenation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results corroborate previous studies that underscore the critical role of SIRT2 and the necessity of maintaining its expression across various cell types (such as macrophages, cardiomyocytes, and vascular smooth muscle cells) to mitigate age-related inflammation, insulin resistance, cardiac dysfunction, and vascular remodeling (He et al., 2020;Ye et al., 2023;Zhang et al., 2023).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Zhang et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900 · cited 4×
“Cytoplasmic and nuclear factors can regulate mROS by targeting enzymes located in the mitochondria.(32) However, the regulatory mechanism underlying cytoplasm/nucleus–mitochondria–mROS signalling in vascular ageing remains largely unknown.”
BackgroundMethodInfluentialSelf-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
The intersection between aging and cardiovascular disease
North, B. J., & Sinclair, D. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246876 · Cited by 1,585
Demographic and epidemiologic drivers of global cardiovascular mortality
Roth, G. A., Forouzanfar, M. H., Moran, A. E., Barber, R., Nguyen, G., Feigin, V. L., Naghavi, M., Mensah, G. A., & Murray, C. J. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406656 · Cited by 1,188
Undulating changes in human plasma proteome profiles across the lifespan
Lehallier, B., Gate, D., Schaum, N., Nanasi, T., Lee, S. E., Yousef, H., Moran Losada, P., Berdnik, D., Keller, A., Verghese, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0673-2 · Cited by 981 · cited 1×
“Notably, we showed that circulating SIRT2 protein levels declined with ageing in humans.(70) These findings revealed one possibility that loss of circulating SIRT2 may serve as a biomarker for biological ageing and a prognostic factor for ageing-related vascular diseases and complications.”
BackgroundMills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930
Ungvari, Z., Tarantini, S., Donato, A. J., Galvan, V., & Csiszar, A. (2018) · Circulation Research · doi:10.1161/circresaha.118.311378 · Cited by 919
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · cited 2×
“Mitochondrial reactive oxygen species–targeted drugs show therapeutic values for treating cardiovascular diseases.(30,31) Cytoplasmic and nuclear factors can regulate mROS by targeting enzymes located in the mitochondria.”
BackgroundMethod
Research works printed but not linked: 78
- Camici, 2017, Aging: the next cardiovascular disease?, Eur Heart J, 38, 1621, 10.1093/eurheartj/ehx239 · DOI
- Paneni, 2017, The aging cardiovascular system: understanding it at the cellular and clinical levels, J Am Coll Cardiol, 69, 1952, 10.1016/j.jacc.2017.01.064 · DOI · Paper page
- Grunewald, 2021, Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span, Science, 373, 10.1126/science.abc8479 · DOI · Paper page
- Kane, 2018, Sirtuins and NAD+ in the development and treatment of metabolic and cardiovascular diseases, Circ Res, 123, 868, 10.1161/CIRCRESAHA.118.312498 · DOI · Paper page
- Abdellatif, 2021, NAD+ metabolism in cardiac health, aging, and disease, Circulation, 144, 1795, 10.1161/CIRCULATIONAHA.121.056589 · DOI · Paper page
- Yoshino, 2021, Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women, Science, 372, 1224, 10.1126/science.abe9985 · DOI · Paper page
- Korotkov, 2021, Sirtuin 6: linking longevity with genome and epigenome stability, Trends Cell Biol, 31, 994, 10.1016/j.tcb.2021.06.009 · DOI
- Winnik, 2015, Protective effects of sirtuins in cardiovascular diseases: from bench to bedside, Eur Heart J, 36, 3404, 10.1093/eurheartj/ehv290 · DOI · Paper page
- Camici, 2015, Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease, Eur Heart J, 36, 3392, 10.1093/eurheartj/ehv587 · DOI · Paper page
- Grootaert, 2022, Sirtuins in atherosclerosis: guardians of healthspan and therapeutic targets, Nat Rev Cardiol, 19, 668, 10.1038/s41569-022-00685-x · DOI
- Liu, 2017, Loss of NAD-dependent protein deacetylase sirtuin-2 alters mitochondrial protein acetylation and dysregulates mitophagy, Antioxid Redox Signal, 26, 849, 10.1089/ars.2016.6662 · DOI
- Eskandarian, 2013, A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection, Science, 341, 10.1126/science.1238858 · DOI · Paper page
- Sun, 2023, Acylations in cardiovascular biology and diseases, what’s beyond acetylation, EBioMedicine, 87, 10.1016/j.ebiom.2022.104418 · DOI
- Chen, 2020, Short-chain fatty acid, acylation and cardiovascular diseases, Clin Sci, 134, 657, 10.1042/CS20200128 · DOI · Paper page
- North, 2014, SIRT2 induces the checkpoint kinase BubR1 to increase lifespan, EMBO J, 33, 1438, 10.15252/embj.201386907 · DOI · Paper page
- He, 2020, An acetylation switch of the NLRP3 inflammasome regulates aging-associated chronic inflammation and insulin resistance, Cell Metab, 31, 580, 10.1016/j.cmet.2020.01.009 · DOI · Paper page
- Tang, 2017, SIRT2 acts as a cardioprotective deacetylase in pathological cardiac hypertrophy, Circulation, 136, 2051, 10.1161/CIRCULATIONAHA.117.028728 · DOI · Paper page
- Bertoldo, 2020, NAD+ repletion rescues female fertility during reproductive aging, Cell Rep, 30, 1670, 10.1016/j.celrep.2020.01.058 · DOI · Paper page
- Jablonska, 2022, Sirt2 promotes white matter oligodendrogenesis during development and in models of neonatal hypoxia, Nat Commun, 13, 4771, 10.1038/s41467-022-32462-2 · DOI
- Ma, 2022, Restoring nuclear entry of sirtuin 2 in oligodendrocyte progenitor cells promotes remyelination during ageing, Nat Commun, 13, 1225, 10.1038/s41467-022-28844-1 · DOI
- Sies, 2022, Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology, Nat Rev Mol Cell Biol, 23, 499, 10.1038/s41580-022-00456-z · DOI · Paper page
- Münzel, 2015, Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications, Eur Heart J, 36, 2555, 10.1093/eurheartj/ehv305 · DOI · Paper page
- Luo, 2017, SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity, Eur Heart J, 38, 1389
- Mir, 2020, Structure-functional implications of longevity protein p66Shc in health and disease, Ageing Res Rev, 63, 10.1016/j.arr.2020.101139 · DOI
- Xiao, 2019, Inhibition of S-adenosylhomocysteine hydrolase induces endothelial dysfunction via epigenetic regulation of p66Shc-mediated oxidative stress pathway, Circulation, 139, 2260, 10.1161/CIRCULATIONAHA.118.036336 · DOI
- Costantino, 2019, Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity, Eur Heart J, 40, 383, 10.1093/eurheartj/ehx615 · DOI
- Spescha, 2015, Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke, Eur Heart J, 36, 1590, 10.1093/eurheartj/ehv140 · DOI
- Huang, 2023, The longevity protein p66Shc is required for neonatal heart regeneration, J Mol Cell Cardiol, 177, 21, 10.1016/j.yjmcc.2023.02.004 · DOI
- Zhou, 2011, Repression of p66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction, Circ Res, 109, 639, 10.1161/CIRCRESAHA.111.243592 · DOI · Paper page
- Mengozzi, 2022, Targeting SIRT1 rescues age- and obesity-induced microvascular dysfunction in ex vivo human vessels, Circ Res, 131, 476, 10.1161/CIRCRESAHA.122.320888 · DOI
- Moreau, 2019, Modulatory influence of sex hormones on vascular aging, Am J Physiol Heart Circ Physiol, 316, H522, 10.1152/ajpheart.00745.2017 · DOI
- Zhernakova, 2022, Age-dependent sex differences in cardiometabolic risk factors, Nat Cardiovasc Res, 1, 844, 10.1038/s44161-022-00131-8 · DOI
- Guo, 2003, Variation of mechanical properties along the length of the aorta in C57bl/6 mice, Am J Physiol Heart Circ Physiol, 285, H2614, 10.1152/ajpheart.00567.2003 · DOI
- Dunn, 1965, Pathology of Laboratory Animals, 303
- Ilyas, 2022, Mouse models of atherosclerosis in translational research, Trends Pharmacol Sci, 43, 920, 10.1016/j.tips.2022.06.009 · DOI
- Riehle, 2019, Small animal models of heart failure, Cardiovasc Res, 115, 1838, 10.1093/cvr/cvz161 · DOI · Paper page
- Tang, 2021, Short-chain enoyl-CoA hydratase mediates histone crotonylation and contributes to cardiac homeostasis, Circulation, 143, 1066, 10.1161/CIRCULATIONAHA.120.049438 · doi:10.1161/circulationaha.120.049438
- Zhang, 2022, CCL17 Acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure, J Exp Med, 219, 10.1084/jem.20200418 · DOI
- Zhang, 2023, The chemokine CCL17 is a novel therapeutic target for cardiovascular aging, Signal Transduct Target Ther, 8, 157, 10.1038/s41392-023-01363-1 · DOI
- Wang, 2019, SIRT2: controversy and multiple roles in disease and physiology, Ageing Res Rev, 55, 10.1016/j.arr.2019.100961 · DOI · Paper page
- Boutouyrie, 2021, Arterial stiffness and cardiovascular risk in hypertension, Circ Res, 128, 864, 10.1161/CIRCRESAHA.121.318061 · DOI · Paper page
- Donato, 2018, Mechanisms of dysfunction in the aging vasculature and role in age-related disease, Circ Res, 123, 825, 10.1161/CIRCRESAHA.118.312563 · DOI · Paper page
- Liberale, 2020, Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease, Eur Heart J, 41, 2974, 10.1093/eurheartj/ehz961 · DOI · Paper page
- Liberale, 2022, Inflammation, aging, and cardiovascular disease: JACC review topic of the week, J Am Coll Cardiol, 79, 837, 10.1016/j.jacc.2021.12.017 · DOI · Paper page
- Puca, 2020, Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism, Eur Heart J, 41, 2487, 10.1093/eurheartj/ehz459 · DOI
- Mueller, 2018, Deletion of macrophage low-density lipoprotein receptor-related protein 1 (LRP1) accelerates atherosclerosis regression and increases C-C chemokine receptor type 7 (CCR7) expression in plaque macrophages, Circulation, 138, 1850, 10.1161/CIRCULATIONAHA.117.031702 · DOI
- Forrester, 2018, Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology, Physiol Rev, 98, 1627, 10.1152/physrev.00038.2017 · DOI · Paper page
- Outeiro, 2007, Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease, Science, 317, 516, 10.1126/science.1143780 · DOI · Paper page
- Huang, 2018, Lysine benzoylation is a histone mark regulated by SIRT2, Nat Commun, 9, 3374, 10.1038/s41467-018-05567-w · DOI · Paper page
- Vaquero, 2006, Sirt2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis, Genes Dev, 20, 1256, 10.1101/gad.1412706 · DOI · Paper page
- Palomer, 2022, Epigenetic repression of Wnt receptors in AD: a role for sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters, Mol Psychiatry, 27, 3024, 10.1038/s41380-022-01492-z · DOI
- Delaney, 2021, Histone lysine methacrylation is a dynamic post-translational modification regulated by HAT1 and SIRT2, Cell Discov, 7, 122, 10.1038/s41421-021-00344-4 · DOI
- Pei, 2019, Diurnal oscillations of endogenous H2O2 sustained by p66Shc regulate circadian clocks, Nat Cell Biol, 21, 1553, 10.1038/s41556-019-0420-4 · DOI
- Hornbeck, 2019, 15 years of PhosphoSitePlus®: integrating post-translationally modified sites, disease variants and isoforms, Nucleic Acids Res, 47, D433, 10.1093/nar/gky1159 · DOI · Paper page
- Chi, 2022, Exerkine fibronectin type-III domain-containing protein 5/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability, Eur Heart J, 43, 4579, 10.1093/eurheartj/ehac431 · DOI
- Archer, 2010, Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target, Circulation, 121, 2661, 10.1161/CIRCULATIONAHA.109.916098 · DOI · Paper page
- Koplev, 2022, A mechanistic framework for cardiometabolic and coronary artery diseases, Nat Cardiovasc Res, 1, 85, 10.1038/s44161-021-00009-1 · DOI
- Harel, 2019, Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence, Cell, 179, 236, 10.1016/j.cell.2019.08.012 · DOI · Paper page
- Li, 2020, Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue, Circulation, 142, 1374, 10.1161/CIRCULATIONAHA.120.046528 · DOI · Paper page
- Aging Biomarker Consortium, 2023, Biomarkers of aging, Sci China Life Sci, 66, 893, 10.1007/s11427-023-2305-0 · DOI · Paper page
- Grootaert, 2021, SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis, Circ Res, 128, 474, 10.1161/CIRCRESAHA.120.318353 · DOI · Paper page
- Sun, 2020, Vascular endothelium-targeted Sirt7 gene therapy rejuvenates blood vessels and extends life span in a Hutchinson-Gilford progeria model, Sci Adv, 6, 10.1126/sciadv.aay5556 · DOI
- Liberale, 2021, Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system, Cardiovasc Res, 117, 2275, 10.1093/cvr/cvaa268 · DOI
- Zhang, 2021, Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury, Redox Biol, 47, 10.1016/j.redox.2021.102141 · DOI
- Ren, 2022, SIRT6 in vascular diseases, from bench to bedside, Aging Dis, 13, 1015, 10.14336/AD.2021.1204 · DOI
- Zhang, 2016, Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in Sirt6 heterozygous mice, Sci Rep, 6, 23912, 10.1038/srep23912 · DOI
- Chen, 2016, Age-associated sirtuin 1 reduction in vascular smooth muscle links vascular senescence and inflammation to abdominal aortic aneurysm, Circ Res, 119, 1076, 10.1161/CIRCRESAHA.116.308895 · DOI · Paper page
- Wan, 2014, SIRT1-mediated epigenetic downregulation of plasminogen activator inhibitor-1 prevents vascular endothelial replicative senescence, Aging Cell, 13, 890, 10.1111/acel.12247 · DOI
- Dikalova, 2020, Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress, Circ Res, 126, 439, 10.1161/CIRCRESAHA.119.315767 · DOI · Paper page
- Tang, 2017, Mitochondrial sirtuins in cardiometabolic diseases, Clin Sci, 131, 2063, 10.1042/CS20160685 · DOI
- Yang, 2017, Functional genetic variants within the SIRT2 gene promoter in acute myocardial infarction, PLoS One, 12
- Jing, 2016, A SIRT2-selective inhibitor promotes c-Myc oncoprotein degradation and exhibits broad anticancer activity, Cancer Cell, 29, 297, 10.1016/j.ccell.2016.02.007 · DOI · Paper page
- Rumpf, 2015, Selective Sirt2 inhibition by ligand-induced rearrangement of the active site, Nat Commun, 6, 6263, 10.1038/ncomms7263 · DOI · Paper page
- Gong, 2022, miR-146a impedes the anti-aging effect of AMPK via NAMPT suppression and NAD+/SIRT inactivation, Signal Transduct Target Ther, 7, 66, 10.1038/s41392-022-00886-3 · DOI
- Carlomosti, 2017, Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1, and eNOS, Antioxid Redox Signal, 27, 328, 10.1089/ars.2016.6643 · DOI
- Melov, 1998, A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase, Nat Genet, 18, 159, 10.1038/ng0298-159 · DOI · Paper page
- Zhang, 2022, An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damage, Redox Biol, 50, 10.1016/j.redox.2022.102238 · DOI
- Zhao, 2010, Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity, Nat Cell Biol, 12, 665, 10.1038/ncb2069 · DOI · Paper page
Cited by
Sola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Metadata
- Authors
- Zhang, Y., Wang, X., Li, X.-K., Lv, S.-J., Wang, H.-P., Liu, Y., Zhou, J., Gong, H., Chen, X.-F., Ren, S.-C., Zhang, H., Dai, Y., Cai, H., Yan, B., Chen, H.-Z., & Tang, X.
- Affiliations
- Department of Biochemistry & Molecular Biology, State Key Laboratory of Common Mechanism Research for Major Diseases, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College , 5 Dong Dan San Tiao, Beijing 100005 , China
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University , No.17 People's South Road, Chengdu, Sichuan 610041 , China
- School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine , 1166 Liutai Avenue, Chengdu, Sichuan 611137 , China
- Department of Nephrology, First Affiliated Hospital of Chengdu Medical College , 783 Xindu Avenue, Chengdu, Sichuan 610500 , China
- Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road , Beijing 10029 , China
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, National Clinical Research Center for Interventional Medicine , 180 Fenglin Road, Shanghai 200032 , China
- Division of Molecular Medicine, Department of Anesthesiology, David Geffen School of Medicine at University of California Los Angeles , Los Angeles, CA 90095 , USA
- Institute of Precision Medicine, Jining Medical University , 133 Hehua Road, Taibaihu New District, Jining, Shandong 272067 , China
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-06-28
- Volume
- 44
- Issue
- 29
- Pages
- 2746-2759
- ISSN
- 0195-668X
- 1522-9645
- Cited by
- 84
- References
- 16
- Language
- en
- Funders
- National Key Research and Development Project of China (2020YFC2008003 and 2019YFA0801500)
- National Natural Science Foundation of China (81970426, 82030017, 82225007, and 82200437)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS2021-I2M-1-050, CIFMS2021-I2M-1-008, CIFMS2022-I2M-2-002, and CIFM2022-RC180-03)
- Shanghai Clinical Research Center for Interventional Medicine (19MC1910300)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice. https://app.cochat.ai/papers/10.1093/eurheartj/ehad381
- The paper
- Zhang, Y., Wang, X., Li, X.-K., Lv, S.-J., Wang, H.-P., Liu, Y., Zhou, J., Gong, H., Chen, X.-F., Ren, S.-C., Zhang, H., Dai, Y., Cai, H., Yan, B., Chen, H.-Z., & Tang, X. (2023). Sirtuin 2 deficiency aggravates ageing-induced vascular remodelling in humans and mice. European Heart Journal. https://doi.org/10.1093/eurheartj/ehad381
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.